Catalyst Wire Dossier Catalyst Wire Dossier

efavirenz/tenofovir/emtricitabine combination (Atripla/STRs used in regimen)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for efavirenz/tenofovir/emtricitabine combination (Atripla/STRs used in regimen), covering 2011-01-04 to 2011-01-04. Get the full timeline:

Most recent: Clinical Trial Update: FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment [Phase 4]

See pricing